Canada · Delayed Price · Currency is CAD Hydreight Technologies Earnings Call Transcripts
Fiscal Year 2025
-
Q3 saw 132% revenue growth year-over-year, four straight profitable quarters, and strong performance across all verticals, especially with the first full quarter of direct-to-consumer revenue. Over 510,000 orders and 1,100+ licenses validate the platform's scale, with 2026 revenue expected to double.
-
Q2 results exceeded expectations with strong revenue growth, positive cash flow, and successful launch of the third vertical, VSDHOne. Strategic investments, acquisitions, and new product offerings are driving expansion, with guidance for 1.3 million orders by year-end unchanged.
-
A strategic acquisition of a stake in Perfect Scripts enables full-scale pharmacy integration, boosting order volumes, improving margins, and expanding supply chain control. The deal supports rapid growth, operational scalability, and positions the platform for higher profitability and market leadership.
-
The platform is rapidly expanding as a first-mover in compliant digital healthcare, with over 350 licenses sold and aggressive growth plans through organic sales, an accelerator program, and M&A. Compliance, technology, and a unique business model create strong barriers to entry and support robust margins.
Fiscal Year 2024
-
Revenue grew to over $22M in 2024 with positive adjusted EBITDA and strong cash reserves. 2025 targets 30% growth, expansion of product offerings, and execution across three business verticals, supported by strategic investments and new partnerships.